Health Catalyst, Inc. insider trading

HCATNASDAQ

$1.75+0.05 (+2.94%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-37.5%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Unlock quarterly net flow

Key players

SKSimeon KohlChief Executive Officer3.7955%of company
DDDaniel D. BurtonChief Executive Officer1.8511%of company
BABenjamin AlbertCEO1.8449%of company
JAJason AlgerChief Financial Officer0.9366%of company
KLKevin Lee FreemanChief Commercial Officer0.4766%of company
BLBenjamin LandryGeneral Counsel0.4669%of company
LLLinda LlewelynChief People Officer0.4267%of company
SHSteven H. NelsonDirector0.3129%of company
DCDavid Coy RossChief Tech & Product Officer0.2714%of company
DLDaniel LeSueurChief Operating Officer0.2636%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
HCAT	Simeon KohlChief Executive Officer	Open market purchase$105K	+2.1%	$1.79	$105K	Sep 14, 2026	Sep 16, 2026
HCAT	Benjamin LandryGeneral Counsel	Open market sell$72.4K	-21.5%	$2.64	$72.4K	Dec 5, 2025	Dec 9, 2025
HCAT	Julie Larson-GreenDirector	Open market sell$128K	-39.5%	$2.67	$128K	Dec 4, 2025	Dec 9, 2025

End of history · 3 transactions